纳指生物科技ETF(513290)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | UTHR | 联合治疗 | 2400.91 | 1.57% |
| 2024-12-31 | VTRS | Viatris Inc | 2265.01 | 1.48% |
| 2024-12-31 | SNY | 赛诺菲 | 2213.48 | 1.45% |
| 2024-12-31 | NBIX | 神经分泌生物科学 | 2106.48 | 1.38% |
| 2024-12-31 | INCY | 因塞特医疗 | 2028.16 | 1.33% |
| 2024-12-31 | SMMT | Summit Therapeutics Inc | 2005.82 | 1.31% |
| 2024-12-31 | BMRN | 拜玛林制药 | 1909.39 | 1.25% |
| 2024-12-31 | INSM | Insmed Inc | 1882.62 | 1.23% |
| 2024-12-31 | SRPT | Sarepta Therapeutics Inc | 1770.28 | 1.16% |
| 2024-12-31 | RPRX | Royalty Pharma plc-A | 1727.55 | 1.13% |
| 2024-12-31 | BNTX | BioNTech SE ADR | 1705.24 | 1.12% |
| 2024-12-31 | MEDP | Medpace Holdings Inc | 1573.83 | 1.03% |
| 2024-12-31 | PCVX | Vaxcyte Inc | 1555.14 | 1.02% |
| 2024-12-31 | EXEL | 伊克力西斯 | 1449.48 | 0.95% |
| 2024-12-31 | ITCI | Intra-Cellular Therapies Inc | 1349.64 | 0.88% |
| 2024-12-31 | ROIV | Roivant Sciences Ltd | 1312.59 | 0.86% |
| 2024-12-31 | ASND | Ascendis Pharma AS ADR | 1265.63 | 0.83% |
| 2024-12-31 | ONC | 百济神州 | 1248.5 | 0.82% |
| 2024-12-31 | JAZZ | 爵士制药 | 1134.8 | 0.74% |
| 2024-12-31 | RVMD | Revolution Medicines Inc | 1121.51 | 0.73% |
公告&资料
